Literature DB >> 29147971

[Antiplatelet or anticoagulative strategies after surgical/interventional valve treatment].

A Jobs1, T Stiermaier1, S Klotz2, I Eitel3.   

Abstract

At the end of August 2017 the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) published new joint guidelines for the treatment of valvular heart disease. These guidelines incorporate the scientific progress since the last version of the guidelines published in 2012. This article reviews current guideline recommendations for antiplatelet and anticoagulative therapy after surgical/interventional treatment of the aortic and mitral valves and discusses the underlying scientific evidence.

Entities:  

Keywords:  Anticoagulation; Antiplatelet therapy; Heart valve diseases; Mitral valve replacement; Transcatheter aortic valve implantation

Mesh：

Substances：

Year:  2018        PMID： 29147971     DOI： 10.1007/s00059-017-4646-2

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  48 in total

1.  AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves.

Authors:  J Acar; B Iung; J P Boissel; M M Samama; P L Michel; J P Teppe; J C Pony; H L Breton; D Thomas; R Isnard; G de Gevigney; E Viguier; A Sfihi; G Hanania; M Ghannem; A Mirode; C Nemoz
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

2.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

Review 3.  Prosthetic Heart Valve Thrombosis.

Authors:  George D Dangas; Jeffrey I Weitz; Gennaro Giustino; Raj Makkar; Roxana Mehran
Journal:  J Am Coll Cardiol       Date:  2016-12-20       Impact factor: 24.094

4.  Course of early subclinical leaflet thrombosis after transcatheter aortic valve implantation with or without oral anticoagulation.

Authors:  Philipp Ruile; Nikolaus Jander; Philipp Blanke; Simon Schoechlin; Jochen Reinöhl; Michael Gick; Juergen Rothe; Mathias Langer; Jonathon Leipsic; Heinz-Joachim Buettner; Franz-Josef Neumann; Gregor Pache
Journal:  Clin Res Cardiol       Date:  2016-11-16       Impact factor: 5.460

5.  Low-dose acetyl salicylic acid versus oral anticoagulation after bioprosthetic aortic valve replacement. Final report of the ACTION registry.

Authors:  Andrea Colli; Jean-Philippe Verhoye; Robin Heijmen; Manuel Antunes
Journal:  Int J Cardiol       Date:  2012-12-11       Impact factor: 4.164

6.  High risk of thromboemboli early after bioprosthetic cardiac valve replacement.

Authors:  M Heras; J H Chesebro; V Fuster; W J Penny; D E Grill; K R Bailey; G K Danielson; T A Orszulak; J R Pluth; F J Puga
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

Review 7.  Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.

Authors:  S C Cannegieter; F R Rosendaal; E Briët
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

8.  Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-25       Impact factor: 4.191

9.  Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.

Authors:  John Puskas; Marc Gerdisch; Dennis Nichols; Reed Quinn; Charles Anderson; Birger Rhenman; Lilibeth Fermin; Michael McGrath; Bobby Kong; Chad Hughes; Gulshan Sethi; Michael Wait; Tomas Martin; Allen Graeve
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-12       Impact factor: 5.209

10.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Martin B Leon; Craig R Smith; Michael J Mack; Raj R Makkar; Lars G Svensson; Susheel K Kodali; Vinod H Thourani; E Murat Tuzcu; D Craig Miller; Howard C Herrmann; Darshan Doshi; David J Cohen; Augusto D Pichard; Samir Kapadia; Todd Dewey; Vasilis Babaliaros; Wilson Y Szeto; Mathew R Williams; Dean Kereiakes; Alan Zajarias; Kevin L Greason; Brian K Whisenant; Robert W Hodson; Jeffrey W Moses; Alfredo Trento; David L Brown; William F Fearon; Philippe Pibarot; Rebecca T Hahn; Wael A Jaber; William N Anderson; Maria C Alu; John G Webb
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.